Related references
Note: Only part of the references are listed.Association of Inherited Mutations in DNA Repair Genes with Localized Prostate Cancer
Daniel J. Lee et al.
EUROPEAN UROLOGY (2022)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2021)
A 10-gene prognostic signature points to LIMCH1 and HLA-DQB1 as important players in aggressive cervical cancer disease
Mari K. Halle et al.
BRITISH JOURNAL OF CANCER (2021)
The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer
Guangliang Jiang et al.
FRONTIERS IN ONCOLOGY (2021)
Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy
Xingyu Chen et al.
FRONTIERS IN IMMUNOLOGY (2021)
Co-Occurring Alteration of NOTCH and DDR Pathways Serves as Novel Predictor to Efficacious Immunotherapy in NSCLC
Zhimin Zhang et al.
FRONTIERS IN ONCOLOGY (2021)
The germline mutation landscape of cancer susceptibility genes in Chinese patients with upper tract urothelial carcinoma
J. Shengming et al.
EUROPEAN UROLOGY (2021)
Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder
Kaiwei Yang et al.
ONCOLOGIST (2021)
Exploring the Impact of Treatment Switching on Overall Survival from the PROfound Study in Homologous Recombination Repair (HRR)-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Rachel Evans et al.
TARGETED ONCOLOGY (2021)
Copy Number Signatures and Clinical Outcomes in Upper Tract Urothelial Carcinoma
Bao Guan et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
Aurelie Kamoun et al.
EUROPEAN UROLOGY (2020)
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort
Hao Lun Luo et al.
INTERNATIONAL JOURNAL OF UROLOGY (2020)
Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer
Wenjuan Tian et al.
CANCER MEDICINE (2020)
Clonal tumor mutations in homologous recombination genes predict favorable clinical outcome in ovarian cancer treated with platinum-based chemotherapy
Shangyi Luo et al.
GYNECOLOGIC ONCOLOGY (2020)
Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity
Alexandra Borodovsky et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer
Sehhoon Park et al.
MOLECULAR CANCER RESEARCH (2020)
Identification of WDFY3 Neoantigens as Prognostic Markers in Long-term Survivors of Extrahepatic Cholangiocarcinoma
Yingyi Wang et al.
CURRENT CANCER DRUG TARGETS (2020)
Quinoline-Based Molecules Targeting c-Met, EGF, and VEGF Receptors and the Proteins Involved in Related Carcinogenic Pathways
Annamaria Martorana et al.
MOLECULES (2020)
The mutational pattern of homologous recombination (HR)-associated genes and its relevance to the immunotherapeutic response in gastric cancer
Yue Fan et al.
CANCER BIOLOGY & MEDICINE (2020)
Sex difference of mutation clonality in diffuse glioma evolution
Hongyi Zhang et al.
NEURO-ONCOLOGY (2019)
Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes
Dana Sherill-Rofe et al.
GENOME RESEARCH (2019)
Ezh2 controls development of natural killer T cells, which cause spontaneous asthma-like pathology
Damon Tumes et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)
Clonal Relatedness and Mutational Differences between Upper Tract and Bladder Urothelial Carcinoma
Francois Audenet et al.
CLINICAL CANCER RESEARCH (2019)
Macrophages in the microenvironment of head and neck cancer: potential targets for cancer therapy
Diane Evrard et al.
ORAL ONCOLOGY (2019)
Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells
Annette E. Skold et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
Min Yuen Teo et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Plasmacytoid dendritic cell in immunity and cancer
Dana Mitchell et al.
JOURNAL OF NEUROIMMUNOLOGY (2018)
NKT cells - New players in CAR cell immunotherapy?
Katharina Kriegsmann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
Arjun V. Balar et al.
LANCET (2017)
Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations
Jiang Chang et al.
NATURE COMMUNICATIONS (2017)
Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
Noemi Andor et al.
NATURE MEDICINE (2016)
Ultrafast SNP analysis using the Burrows-Wheeler transform of short-read data
Kouichi Kimura et al.
BIOINFORMATICS (2015)
Evaluation of miRNA-binding-site SNPs of MRE11A, NBS1, RAD51 and RAD52 involved in HRR pathway genes and risk of breast cancer in China
Zhenzhen Wu et al.
MOLECULAR GENETICS AND GENOMICS (2015)
The immunoregulatory role of type I and type II NKT cells in cancer and other diseases
Masaki Terabe et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
The Role of CD40 Expression in Dendritic Cells in Cancer Biology; A Systematic Review
Gui Han Lee et al.
CURRENT CANCER DRUG TARGETS (2014)
Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing
Jianjun Zhang et al.
SCIENCE (2014)
Toll-like receptor-4 modulation for cancer immunotherapy
Shanjana Awasthi
FRONTIERS IN IMMUNOLOGY (2014)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
Kristian Cibulskis et al.
NATURE BIOTECHNOLOGY (2013)
ENTPD1/CD39 is a promising therapeutic target in oncology
J. Bastid et al.
ONCOGENE (2013)
CONTRA: copy number analysis for targeted resequencing
Jason Li et al.
BIOINFORMATICS (2012)
Endothelin B Receptor, a New Target in Cancer Immune Therapy
Lana E. Kandalaft et al.
CLINICAL CANCER RESEARCH (2009)
Share Paper
